5 Value Stocks In The Healthcare Sector
5 Value Stocks In The Healthcare Sector
The Meaning Behind Value Stocks
价值股背后的意义
A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued.
传统上，与同行业公司的股票价格相比，价值股票的价格较低。这表明该公司的估值可能被低估了，因为投资者对此类公司的兴趣不大。最常用的价值检查方法是市盈倍数或市盈率。低市盈倍数很好地表明股票被低估了。
The following stocks are considered to be notable value stocks in the healthcare sector:
以下股票被认为是医疗保健领域值得注意的价值股票：
- Kiora Pharmaceuticals (NASDAQ:KPRX) - P/E: 0.76
- Viatris (NASDAQ:VTRS) - P/E: 8.96
- InMode (NASDAQ:INMD) - P/E: 9.28
- Solid Biosciences (NASDAQ:SLDB) - P/E: 0.14
- Exicure (NASDAQ:XCUR) - P/E: 0.34
- 基奥拉制药（纳斯达克股票代码：KPRX）——市盈率：0.76
- Viatris（纳斯达克股票代码：VTRS）——市盈率：8.96
- InMode（纳斯达克股票代码：INMD）——市盈率：9.28
- Solid Biosciences（纳斯达克股票代码：SLDB）——市盈率：0.14
- Exicure（纳斯达克股票代码：XCUR）——市盈率：0.34
Kiora Pharmaceuticals has reported Q3 earnings per share at $-0.89, which has decreased by 12.66% compared to Q2, which was -0.79. This quarter, Viatris experienced an increase in earnings per share, which was $0.75 in Q2 and is now $0.79. Most recently, the company reported a dividend yield of 5.18%, which has increased by 0.59% from last quarter's yield of 4.59%.
Kiora Pharmicals公布的第三季度每股收益为-0.89美元，与第二季度的-0.79美元相比下降了12.66％。本季度，Viatris的每股收益有所增加，第二季度为0.75美元，目前为0.79美元。最近，该公司公布的股息收益率为5.18％，较上个季度的4.59％的收益率增长了0.59％。
Most recently, InMode reported earnings per share at $0.71, whereas in Q3 earnings per share sat at $0.61. This quarter, Solid Biosciences experienced an increase in earnings per share, which was $-1.25 in Q2 and is now $-1.05. Exicure saw an increase in earnings per share from -0.7 in Q1 to $-0.68 now.
最近，InMode公布的每股收益为0.71美元，而第三季度的每股收益为0.61美元。本季度，Solid Biosciences的每股收益有所增加，第二季度为-1.25美元，目前为-1.05美元。Exicure的每股收益从第一季度的-0.7美元增长到现在的-0.68美元。
These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.
这5只价值股是Benzinga Insights根据量化分析选择的。尽管这种有条理的判断过程并不意味着做出最终决定，但我们的技术可以让投资者对该行业有更多的认识。
译文内容由第三方软件翻译。